Company Number: 13388127

Analysis Date: 2025-07-29 19:41 UTC

1. Risk Rating: LOW
   Rubix Therapy Ltd demonstrates a stable financial position with positive net current assets, no overdue filings, and no indications of insolvency or regulatory non-compliance. The company’s current liabilities are comfortably covered by cash and other current assets, indicating low solvency and liquidity risk.

2. Key Concerns:

• Declining Net Assets: Shareholders’ funds have decreased steadily from £17,614 in 2021 to £5,608 in 2025, which may reflect operational losses or capital withdrawals that warrant investigation.
• Single Director and Shareholder Control: The company is wholly controlled by one individual, which could present governance risks or succession concerns.
• Limited Employee Base: With only one employee (the director), operational continuity and scalability may be constrained, impacting sustainability.

3. Positive Indicators:

• Positive Working Capital: Net current assets remain positive across all reported years, indicating the company can meet short-term obligations.
• Compliance with Filing Requirements: No overdue accounts or confirmation statements, suggesting good regulatory compliance.
• Stable Cash Position: Despite a reduction, cash balances have remained positive and sufficient to cover current liabilities.

4. Due Diligence Notes:

• Review the reasons behind the consistent decrease in shareholders’ funds to understand if this is due to trading losses, dividends, or other factors.
• Obtain management accounts or cash flow forecasts to assess operational sustainability and liquidity beyond the balance sheet snapshot.
• Verify the nature of liabilities classified as “other creditors” to assess potential contingent risks.
• Confirm the absence of any director disqualifications, related party transactions, or legal proceedings that could impact governance or financial health.
• Evaluate the business model and market positioning given the single employee and owner structure to understand growth prospects and operational risks.